Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Xiamen Zeesan Biotech Co. Ltd. currently has 1 pending office action in the Chemistry & Materials technology area. The company's patent activity is restricted to 1 distinct art unit and involves 1 distinct examiner. This indicates a narrow and specialized focus within the chemistry field. For the applicant, this means the entire success of the current portfolio rests on a single thread of interaction within the USPTO. The concentration in a single technology area further emphasizes the specialized nature of these filings.
Brittany I Fisher is the busiest examiner, handling the 1 pending office action. Since there is only 1 distinct examiner and 1 art unit, the prosecution strategy is straightforward. This lack of variety in examiners and art units means the outcome of the current portfolio depends on the interactions with this specific official. Practitioners should prioritize understanding the specific examination history and preferences of this examiner, as there are no other pending matters to provide alternative paths to allowance. Navigating this single relationship is the central task for the company's legal representatives.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FISHER, BRITTANY I | 1 | 84.5% | +12.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260547 | REAGENT CONTAINER AND OPERATION METHOD THEREFOR, AND REAGENT TREATMENT SYSTEM | FISHER, BRITTANY I | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18260547 | REAGENT CONTAINER AND OPERATION METHOD THEREFOR, AND REAGENT TREATMENT SYSTEM | FISHER, BRITTANY I | — |
| Art Unit | Apps |
|---|---|
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18260547 | REAGENT CONTAINER AND OPERATION METHOD THEREFOR, AND REAGENT TREATMENT SYSTEM | FISHER, BRITTANY I | 1796 | §102§112 | Non-Final OA | — | Pending | Aug 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialXiamen Zeesan Biotech Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Brittany I Fisher has the most, with 1 of Xiamen Zeesan Biotech Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
